SCHEMBL205076

SCHEMBL205076

CCN(CC)S(=O)(=O)c1ccc(Nc2ccc(Br)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
HTT P42858 3/20 0.58
ALDH1A1 P00352 6/20 0.54
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
MAPT P10636 3/20 0.51
HSP90AA1 P07900 1/20 0.51
MAPK1 P28482 1/20 0.51
HPGD P15428 2/20 0.50
KDM4E B2RXH2 1/20 0.50
TSHR P16473 1/20 0.48
ABCC9 O60706 1/20 0.48
ABCC8 Q09428 1/20 0.48
KCNJ11 Q14654 1/20 0.48
KCNJ8 Q15842 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2932439 0.89 LMNA (0.70) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL205074 0.85 SMN1; SMN2 (0.67) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL205075 0.79 ALDH1A1 (0.51) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL2706548 0.79 ALDH1A1 (0.60) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL14283242 0.79 LMNA (0.66) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL6951902 0.77 LMNA (0.63) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL6035034 0.77 LMNA (0.53) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL2932532 0.75 CA9 (0.62) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL11139693 0.75 LMNA (0.67) LMNASMN1; SMN2HTTALDH1A1NPC1
SCHEMBL16568638 0.74 L3MBTL1 (0.64) LMNAALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 LMNA 2668/4885SMN1; SMN2 3252/4885HTT 809/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 LMNA 2668/4885SMN1; SMN2 3252/4885HTT 809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.